Rare McKinsey Statement Stops Short Of Apology After Helping Purdue Pharma ‘Turbocharge’ Opioid Sales Amid Epidemic
Published
'Our work for Purdue fell short of that standard'
Full ArticlePublished
'Our work for Purdue fell short of that standard'
Full ArticleThe corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One..
Facing mounting pressure about its role in the opioid crisis, McKinsey has taken the unusual step of acknowledging that its work..